In conclusion, we here provided the first evidence of significantly high reactivity to proinsulin and MAP-derived homologous peptides in the context of HT, with distinct prevalence in 51–60 year-old women and in 31–40 year-old men. This evidence concerns the gene INS and hematocrit.